Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogram.

Meijer HJ, Debats OA, Roach M 3rd, Span PN, Witjes JA, Kaanders JH, van Lin EN, Barentsz JO.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1186-91. doi: 10.1016/j.ijrobp.2012.02.039. Epub 2012 Apr 18.

PMID:
22520482
2.

High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.

Meijer HJ, van Lin EN, Debats OA, Witjes JA, Span PN, Kaanders JH, Barentsz JO.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1405-10. doi: 10.1016/j.ijrobp.2011.04.054. Epub 2011 Jun 2.

PMID:
21640507
3.

A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.

Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein E, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW.

J Urol. 2003 Nov;170(5):1798-803.

PMID:
14532779
4.

Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.

Godoy G, Chong KT, Cronin A, Vickers A, Laudone V, Touijer K, Guillonneau B, Eastham JA, Scardino PT, Coleman JA.

Eur Urol. 2011 Aug;60(2):195-201. doi: 10.1016/j.eururo.2011.01.016. Epub 2011 Jan 18.

PMID:
21257258
5.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
6.

Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.

Johnson SB, Hamstra DA, Jackson WC, Zhou J, Foster B, Foster C, Song Y, Li D, Palapattu GS, Kunju L, Mehra R, Sandler H, Feng FY.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):275-81. doi: 10.1016/j.ijrobp.2013.05.043. Epub 2013 Jul 23.

PMID:
23886418
8.

Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.

Moreira DM, Jayachandran J, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Stephenson AJ, Freedland SJ.

BJU Int. 2009 Nov;104(10):1452-6. doi: 10.1111/j.1464-410X.2009.08623.x. Epub 2009 May 18.

9.

Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse.

Weidner AM, van Lin EN, Dinter DJ, Rozema T, Schoenberg SO, Wenz F, Barentsz JO, Lohr F.

Strahlenther Onkol. 2011 Mar;187(3):206-12. doi: 10.1007/s00066-010-2195-1. Epub 2011 Feb 21.

PMID:
21347637
10.
11.

Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.

Briganti A, Karnes RJ, Joniau S, Boorjian SA, Cozzarini C, Gandaglia G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Sun M, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T.

Eur Urol. 2014 Sep;66(3):479-86. doi: 10.1016/j.eururo.2013.11.045. Epub 2013 Dec 12.

PMID:
24345725
13.

Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.

Walz J, Bladou F, Rousseau B, Laroche J, Salem N, Gravis G, Briganti A, Chun FK, Karakiewicz PI, Fournier G.

Urology. 2012 Mar;79(3):546-51. doi: 10.1016/j.urology.2011.11.036.

PMID:
22386393
14.

External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.

Gacci M, Schiavina R, Lanciotti M, Masieri L, Serni S, Vagnoni V, Abdollah F, Carini M, Martorana G, Montorsi F.

Urol Int. 2013;90(3):277-82. doi: 10.1159/000343993. Epub 2012 Dec 22.

PMID:
23296120
15.

Predicting pelvic lymph node involvement in current-era prostate cancer.

Rahman S, Cosmatos H, Dave G, Williams S, Tome M.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):906-10. doi: 10.1016/j.ijrobp.2010.11.053. Epub 2011 Feb 6.

PMID:
21300478
16.

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.

Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F.

Eur Urol. 2012 Mar;61(3):480-7. doi: 10.1016/j.eururo.2011.10.044. Epub 2011 Nov 7.

PMID:
22078338
17.
18.

Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.

Liauw SL, Pitroda SP, Eggener SE, Stadler WM, Pelizzari CA, Vannier MW, Oto A.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):378-84. doi: 10.1016/j.ijrobp.2012.05.015. Epub 2012 Jun 18.

PMID:
22717242
19.

Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer.

Jilg CA, Rischke HC, Reske SN, Henne K, Grosu AL, Weber W, Drendel V, Schwardt M, Jandausch A, Schultze-Seemann W.

J Urol. 2012 Dec;188(6):2190-7. doi: 10.1016/j.juro.2012.08.041. Epub 2012 Oct 18.

PMID:
23083862
20.

Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?

MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW.

Urology. 2004 Oct;64(4):760-4.

PMID:
15491716

Supplemental Content

Support Center